臺灣酒癮藥物治療之發展趨勢

李若琦 ； 楊凱鈞

《臨床醫學月刊》 85卷4期 (2020/04) Pp. 202-205

https://doi.org/10.6666/ClinMed.202004_85(4).0036

摘要

酒精使用障礙者（alcohol use disorder, AUD）在維持治療的時期，可使用藥物降低個案之成癮行為，協助病人達到長期酒精戒治。Disulfiram因副作用大，目前是第二線用藥的角色。Naltrexone及acamprosate兩項口服藥物在國外皆有許多臨床實證，副作用之風險低。衛生福利部已經於2019年准許37間醫療機構以專案進口的方式使用。

關鍵字

酒精使用障礙（alcohol use disorder） ； naltrexone ； acamprosate ； disulfiram

參考文獻

Association AP. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. American Psychiatric Association Publishing 2018.

Stahl SM, Stahl SM, Muntner N. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press; 2013.

Strain EC. Incorporating Alcohol Pharmacotherapies Into Medical Practice: A Treatment Improvement Protocol. DIANE Publishing Company 2010.

Britain) NCC for MH (Great, Britain) NI for H and CE (Great. Alcohol Use Disorders: The NICE Guideline on the Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence. Royal College of Psychiatrists 2011.

Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings: A Systematic Review and Meta-analysis. JAMA 2014;311:1889-900.